News
Prospective controlled study of the recombinant zoster vaccine in autoimmune rheumatic disease: robust seroconversion despite intravenous cyclophosphamide.
Randomized Controlled Trial in Vaccine, 2026 Nov 14. PubMed ID 42843284.
Read the full story at Vaccine, 2026 Nov 14 · PubMed (opens in a new tab)
Email to a friend
Comments
- No comments yet.
Headline and summary from Vaccine, 2026 Nov 14 · PubMed; the full story is on the publisher's site. Nothing here is investment advice.